Lab
Q Answer Lab INC
Q Answer Lab INC was paid $2.68M by Medicaid between Dec 2018 and Nov 2024, across 14 billing codes. Its largest line is U0004, 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r — 70% of everything it billed.
33Billing provider infoQ ANSWER LAB INC
EDISON, NJ 08820
EDISON, NJ 08820
33aNPI1336616960assigned 11/01/2018
33bProvider typeClinical Medical Laboratory
28Total paid$2.68M
24GClaims136,896
24DCodes billed14
24AFirst – last monthDec 2018 – Nov 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in New Jersey
Rank by total paid#48 of 122
Median peer was paid$1.29M
This provider vs. median2.1×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 117 | $8K | |
| 2019 | 356 | $18K | |
| 2020 | 14,360 | $436K | |
| 2021 | 69,329 | $1.43M | |
| 2022 | 22,258 | $459K | |
| 2023 | 24,277 | $269K | |
| 2024incomplete | 6,199 | $59K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | 70% | 46,368 | 15,638 | $1.87M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 14% | 36,935 | 12,086 | $377K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 6.8% | 18,371 | 6,277 | $183K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 5.2% | 27,878 | 9,115 | $138K |
| 87150 | 1.5% | 1,352 | 1,048 | $40K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 277 | 218 | $26K |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 1,713 | 1,360 | $14K |
| 87631 | <1% | 502 | 347 | $9K | |
| 87640 | <1% | 934 | 684 | $6K | |
| 87486 | <1% | 1,022 | 770 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 831 | 594 | $5K |
| 87481 | <1% | 572 | 530 | $2K |
2 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialATIT, NEELAM (BILLING & CREDENTIALING ADMIN)